Position in INCY
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$12,866,580
+$6,617,502 QoQ
Shares Held
136,704
+116.1% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 61.786048689138575.ToString("F0")%
Shared 0.ToString("F0")%
None 38.21395131086142.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026INTECH INVESTMENT MANAGEMENT LLC holds $193,154,031 across 175 Biotechnology names. INCY ranks #3 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
68,009 | $22,502,137 | |
| 2 | EXEL |
Exelixis, Inc.
|
401,748 | $17,230,971 | |
| 3 | INCY |
Incyte Corp
This page
|
136,704 | $12,866,580 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
162,864 | $10,525,900 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19,713 | $8,802,642 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,319 | $7,200,231 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
34,379 | $6,499,349 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
55,949 | $3,811,805 |
All Filings in INCY
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,866,580 | 136,704 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $6,249,078 | 63,269 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $4,278,918 | 50,453 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,751,949 | 69,779 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,016,798 | 33,308 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $2,004,963 | 29,028 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,115,121 | 62,256 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $6,434,994 | 106,153 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,977,650 | 52,267 | Shares | Sole | 2024-08-02 | |
| 2023-12-31 | $5,505,301 | 87,678 | Shares | Sole | 2024-10-18 | |
| 2023-09-30 | $7,418,014 | 128,406 | Shares | Sole | 2024-10-18 | |
| 2023-06-30 | $14,388,651 | 231,143 | Shares | Sole | 2024-10-18 | |
| 2023-03-31 | $17,664,594 | 244,425 | Shares | Sole | 2024-10-18 | |
| 2022-12-31 | $13,584,601 | 169,131 | Shares | Defined | 2024-10-18 | |
| 2022-09-30 | $6,822,535 | 102,379 | Shares | Defined | 2024-10-18 | |
| 2022-06-30 | $776,108 | 10,216 | Shares | Sole | 2022-08-10 | |
| No filing history on record for this holder in this stock. | ||||||